6 results match your criteria: "Total Spine Institute[Affiliation]"
Interv Pain Med
September 2025
Total Spine Institute, Los Angeles, CA, USA.
Objective: To assess the effectiveness of dorsal column spinal cord stimulation (SCS) in treating persistent spinal pain syndrome - Type 2 (PSPS-T2).
Design: Systematic review.
Methods: PICOS (Population, Intervention, Comparison, Outcomes, and Studies) criteria were developed to include randomized controlled trials (RCTs) examining dorsal column stimulation for PSPS-T2 compared to conventional medical management or sham.
Neurospine
June 2025
University of California, Irvine; Fullerton Orthopedics, Fullerton, CA, USA.
Postoperative pain is an inevitable consequence of spine surgery, yet there remains no universal consensus on the optimal pain management strategy. The complexity of spine procedures, coupled with patient variability, necessitates a multifaceted approach to pain control. Over time, numerous strategies have emerged, each with varying levels of effectiveness.
View Article and Find Full Text PDFInterv Pain Med
December 2024
Department of Physical and Rehabilitation Medicine, University of Turku, Turku, Finland.
Background: Spinal Cord Stimulation (SCS) is a widely recognized treatment for Complex Regional Pain Syndrome (CRPS), particularly in cases where traditional methods are ineffective. This paper systematically reviews randomized controlled trials to analyze the efficacy of SCS, as well as Dorsal Root Ganglion (DRG) Stimulation in treating CRPS, focusing on its long-term effectiveness.
Methods: This systematic review focused exclusively on randomized controlled trials to assess a primary outcome of improvement in pain symptoms in patients diagnosed with CRPS.
JAAPA
December 2024
At the time this article was written, Chelsey M. Hoffmann was academic co-director of the PA program at the Mayo Clinic School of Health Science in Rochester, Minn. She now practices in the Department of Pain Medicine, Division of Anesthesiology, at the Mayo Clinic in Rochester, Minn. Ryan Mattie pr
This article describes minimally invasive treatments for managing chronic low back pain (LBP) related to lumbar spinal stenosis, facetogenic LBP, vertebrogenic LBP, or discogenic LBP. We also propose a clinical decision-making tool to guide clinicians in appropriate patient selection for various treatments.
View Article and Find Full Text PDFIntroduction: Interventional treatment options for the lumbar degenerative spine have undergone a significant amount of innovation over the last decade. As new technologies emerge, along with the surgical specialty expansion, there is no manuscript that utilizes a review of surgical treatments with evidence rankings from multiple specialties, namely, the interventional pain and spine communities. Through the Pacific Spine and Pain Society (PSPS), the purpose of this manuscript is to provide a balanced evidence review of available surgical treatments.
View Article and Find Full Text PDFInterv Pain Med
December 2022
University of Utah School of Medicine, Department of Physical Medicine & Rehabilitation, Salt Lake City, UT, USA.
This series of FactFinders presents a brief summary of the evidence and outlines recommendations regarding the use of antibiotics for disc access and spinal cord stimulation trials. The evidence in support of the following facts is presented: (1) There is a low but nonzero risk of discitis due to percutaneous intervertebral disc access. Strategies to mitigate this risk include use of strict aseptic technique, use of a needle stylet, and prophylactic intravenous or intra-discal antibiotics.
View Article and Find Full Text PDF